Eli Lilly & Co. (LLY) Tops Q1 EPS by 49c, Updates Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500, Nasdaq edge higher ahead of midterm results; Apple falls
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $1,422.12 +0.79%
Financial Fact:
Marketing, selling, and administrative: 1.57B
Today's EPS Names:
INM, TRI, CRVL, More
Financial Fact:
Marketing, selling, and administrative: 1.57B
Today's EPS Names:
INM, TRI, CRVL, More
Join SI Premium – FREE
(Updated - April 28, 2022 6:30 AM EDT)
Eli Lilly & Co. (NYSE: LLY) reported Q1 EPS of $2.62, $0.49 better than the analyst estimate of $2.13. Revenue for the quarter came in at $7.81 billion versus the consensus estimate of $6.68 billion.
GUIDANCE:
Eli Lilly & Co. sees FY2022 EPS of $8.15-$8.30, versus the consensus of $8.19. The company sees revenue to be between $28.8 billion and $29.3 billion vs consensus of $26.8 billion.
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Sotera Health Co. (SHC) Tops Q3 EPS by 2c; Offers Guidance
- Tigress Financial Partners Reiterates Buy Rating on Jersey Mike's Subs (JMKE)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
